MDxHealth SA (MDXH.BR) Stock Analyst Earnings Estimates
EBR:MDXH - Euronext Brussels - BE0974461940 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.46M 56.57% | 22.24M 20.48% | 37.05M 66.59% | 70.745M 90.94% | 83.282M 17.72% | 112.2M 34.72% | 113.21M 0.90% | 129.96M 14.80% | |
| EBITDA YoY % growth | -23.52M 29.71% | -23.8M -1.19% | -32.95M -38.45% | -21.782M 33.89% | -12.427M 42.95% | -1.924M 84.52% | 11.985M 723.01% | 26.508M 121.18% | |
| EBIT YoY % growth | -26.85M 27.20% | -26.84M 0.04% | -37.86M -41.06% | -27.384M 27.67% | -20.914M 23.63% | -10.779M 48.46% | 3.96M 136.74% | 18.072M 356.36% | |
| Operating Margin | -145.45% | -120.68% | -102.19% | -38.71% | -25.11% | -9.61% | 3.50% | 13.91% | |
| EPS YoY % growth | N/A 12.92% | N/A -363.99% | -0.10 99.44% | -6.62 -6,519.80% | -5.18 21.73% | -0.34 93.50% | 0.10 129.09% | 0.61 521.98% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.09 -90.09% | -2.09 -4,082.00% | -1.89 -529.00% | -1.84 -359.00% | -1.58 24.39% |
| Revenue Q2Q % growth | 19.605M -18.48% | 18.423M 25.33% | 20.128M -36.00% | 20.766M 7.32% | 23.931M 22.07% |
| EBITDA Q2Q % growth | -5.576M 65.08% | -4.846M 31.52% | -4.28M 67.20% | -4.243M -689.33% | -3.848M 30.99% |
| EBIT Q2Q % growth | -7.417M 64.48% | -6.415M 26.41% | -6.333M 61.53% | -6.129M -34.40% | -2.618M 64.71% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.40 -700.00% | -2.24 | 1.84 | 82.17% |
| Q2 2023 Q2Q % growth | -0.30 | -3.14 | 2.84 | 90.44% |
| Q1 2023 Q2Q % growth | -0.05 | -3.47 | 3.42 | 98.56% |
| Q4 2022 Q2Q % growth | -1.10 | -6.66 | 5.56 | 83.49% |
| Q3 2022 Q2Q % growth | -0.05 | -5.41 | 5.36 | 99.08% |
| Q2 2020 Q2Q % growth | -1.80 | -1.63 | -0.17 | -10.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 19.35M 73.48% | 18.213M | 1.137M | 6.24% |
| Q2 2023 Q2Q % growth | 31.45M 141.74% | 14.143M | 17.307M | 122.37% |
| Q1 2023 Q2Q % growth | 14.7M | 12.489M | 2.211M | 17.70% |
| Q4 2022 Q2Q % growth | 24.05M 108.95% | 11.169M | 12.881M | 115.33% |
| Q3 2022 Q2Q % growth | 11.154M | 9.761M | 1.393M | 14.27% |
| Q2 2022 Q2Q % growth | 13.01M 21.25% | % | ||
| Q4 2021 Q2Q % growth | 11.51M 34.15% | % | ||
| Q2 2021 Q2Q % growth | 10.73M 8.60% | % | ||
| Q4 2020 Q2Q % growth | 8.58M 842.86% | % | ||
| Q2 2020 Q2Q % growth | 9.88M -9.11% | 11.883M | -2.003M | -16.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | -889.37% | -731.51% |
| Revenue | N/A | N/A | -0.5% | 1.18% |